Interview with Anna Gajec, General Manager, Cegedim Poland
Given Cegedim’s global reach and your 13 year experience of operating as a consultant to the Polish pharma industry, how would you describe the market to the international readers of…
Address: Al. Jerozolimskie 136
02-305 Warszawa
Al. Jerozolimskie 136
02-305 Warszawa
Al. Jerozolimskie 136
02-305 Warszawa
Al. Jerozolimskie 136 – 02-305 Warszawa, Poland
Tel: +48 22 389 1000
Web: http://www.cegedim.com/Pages/default.aspx
Cegedim Relationship Management helps its Life Sciences clients strengthen their customer relationships, enhance sales effectiveness, optimize data quality, improve marketing performance, and mitigate regulatory compliance risks. With a presence in more than 80 countries, Cegedim Relationship Management combines its global expertise with a deep understanding of local markets to help clients promote and market their products in the most efficient and cost-effective manner.
Leveraging our industry experience with specialized insight into commercial models and federal and state regulations, Cegedim Relationship Management offers companies of all sizes a targeted approach to optimizing growth within the evolving Life Sciences industry.
Cegedim Relationship Management provides commercial, regulatory compliance and data optimization solutions for the Life Sciences industry, enabling targeted solutions for strengthened client customer relationships, enhanced sales effectiveness, improved marketing performance and mitigated regulatory compliance risks.
Given Cegedim’s global reach and your 13 year experience of operating as a consultant to the Polish pharma industry, how would you describe the market to the international readers of…
“Innovation is about bringing new chemical compounds on the market; but it is also, and sometimes even more, to continue the therapeutic development of the drugs which are already there”…
Merck’s managing director discusses the importance of diversification to succeed in Poland by saying: “Nowadays, in such a dynamic environment the healthy level of diversification that Merck offers is becoming…
Medtronic’s country director brings some interesting perspectives on the differences between the pharma and medical device regulations in Poland by saying: “the medical device industry is discriminated against, as we…
The founder of PBA Consultancy offers a critical analysis of the new Reimbursement Act, looking at what could still be done to improve the system. Could you give us the…
The founder of PBA Consultancy offers a critical analysis of the new Reimbursement Act, looking at what could still be done to improve the system. Could you give us the…
The founder of PBA Consultancy offers a critical analysis of the new Reimbursement Act, looking at what could still be done to improve the system. Could you give us the…
Poland’s Main Pharmaceutical Inspector discusses the dangers behind falsified medicines and the need to control internet pharmacies. She also showcases the great power Poland holds as a manufacturing country with…
“In this very competitive environment, patents give companies an edge; this is why we must maintain innovative breakthroughs in our industry. This will then allow us to compete more efficiently…
“The overall Polish healthcare system is quite good. Of course, there are flaws, but Poland is equipped to treat almost any disease. The flaws in the system stem from historically…
In a world where diabetes increasingly more common, Poland has not been spared, with 2.5 million diabetic patients currently, and with a further 750,000 still unaware of their condition. In…
Cezary Sledziewski, Executive Director of PZPPF, discusses the pros and cons of Poland’s catching up with EU’s rising standards. He argues: “No one currently knows exactly how much these costs…
Polpharma , Poland’s role model and largest Polish manufacturer of drug products and active pharmaceutical ingredients, has pushed the Polish boundaries with the objective to become the fastest growing regional…
See our Cookie Privacy Policy Here